Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Harrison Seth Loring
Relationship:   Director
City:   Sydney, Nsw
State:   C3
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   10,594,431    

Indirect Shares

   25,221,855      
Direct Value   $5,034,895    

Indirect Value

   $19,819,758      
Total Shares   35,816,286      
Total Value   $24,854,653      


Titan Pharmaceuticals Inc $4,246,000 Eledon Pharmaceuticals Ord Shs $532,798 Avalo Therapeutics, Inc $256,097 Akero Therapeutics, Inc. $0 Titan Pharmaceuticals Inc $4,246,000 Eledon Pharmaceuticals Ord Shs $532,798 Avalo Therapeutics, Inc $256,097 Akero Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            HeartWare International Inc HTWR Director 2016-08-23 0 2016-08-23 0    Premium*  
            Titan Pharmaceuticals Inc TTNP 10% Owner 2013-11-25 9,650,000 0    Premium*  
            Eledon Pharmaceuticals Ord Shs ELDN Director, 10% Owner 2014-09-22 212,694 2014-09-22 7,912,079    Premium*  
            Avalo Therapeutics, Inc AVTX Director, 10% Owner 2015-10-20 595,436 2015-10-20 0    Premium*  
            Stoke Therapeutics, Inc. STOK Director, 10% Owner 2019-06-21 0 2020-11-24 17,161,713    Premium*  
            Akero Therapeutics, Inc. AKRO Director 2022-11-30 136,301 2022-11-30 148,063    Premium*  
* Premium Members only  

Records found :    89         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AKRO Akero Therapeutics, Inc. Director   –       •       •   2019-06-24 4 B $16.00 $14,400,000 I/I 900,000 5,415,203 2.25 -
AKRO Akero Therapeutics, Inc. Director   –       •       •   2019-06-24 4 A $0.00 $0 I/I 4,515,203 4,515,203 0 -
AKRO Akero Therapeutics, Inc. Director   –       •       •   2020-07-10 4 B $36.00 $14,940,000 I/I 415,000 5,830,203 2.25 -
AKRO Akero Therapeutics, Inc. Director   –       •      –    2022-10-25 4 S $44.92 $220,359 I/I (4,906) 326,813 0 -
AKRO Akero Therapeutics, Inc. Director   –       •      –    2022-10-25 4 S $44.92 $202,797 D/D (4,515) 300,851 0 -
AKRO Akero Therapeutics, Inc. Director   –       •      –    2022-10-26 4 S $43.08 $3,131,402 I/I (71,583) 255,230 0 -
AKRO Akero Therapeutics, Inc. Director   –       •      –    2022-10-26 4 S $43.08 $2,882,142 D/D (65,885) 234,966 0 -
AKRO Akero Therapeutics, Inc. Director   –       •      –    2022-10-27 4 S $41.12 $2,758,920 D/D (66,426) 168,540 0 -
AKRO Akero Therapeutics, Inc. Director   –       •      –    2022-10-27 4 S $41.12 $2,997,575 I/I (72,172) 183,058 0 -
AKRO Akero Therapeutics, Inc. Director   –       •      –    2022-10-28 4 S $40.28 $925,738 I/I (22,965) 160,093 0 -
AKRO Akero Therapeutics, Inc. Director   –       •      –    2022-10-28 4 S $40.28 $852,091 D/D (21,138) 147,402 0 -
AKRO Akero Therapeutics, Inc. Director   –       •      –    2022-11-30 4 S $46.44 $564,673 I/I (12,030) 148,063 0 -
AKRO Akero Therapeutics, Inc. Director   –       •      –    2022-11-30 4 S $46.44 $521,067 D/D (11,101) 136,301 0 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2015-10-20 4 A $0.00 $0 D/D 595,436 595,436 0 -
ELDN Eledon Pharmaceuticals Or... Director   –       •       •   2014-09-16 3 IO $0.00 $0 D/D 0 212,694 -
ELDN Eledon Pharmaceuticals Or... Director   –       •       •   2014-09-16 3 IO $0.00 $0 I/I 0 9 -
ELDN Eledon Pharmaceuticals Or... Director   –       •       •   2014-09-22 4 B $15.00 $5,437,500 I/I 362,500 7,912,079 2.25 -
ELDN Eledon Pharmaceuticals Or... Director   –       •       •   2014-09-22 4 A $0.00 $0 I/I 7,549,570 7,549,579 0 -
HTWR HeartWare International I... Director   –       •      –    2007-06-28 3 IO $0.00 $0 I/I 0 91,588,782 -
HTWR HeartWare International I... Director   –       •      –    2008-08-13 4 B $0.52 $85,540 I/I 164,500 92,488,782 2.1 -
HTWR HeartWare International I... Director   –       •      –    2008-08-13 4 B $0.52 $382,460 I/I 735,500 92,324,282 2.1 -
HTWR HeartWare International I... Director   –       •      –    2008-08-15 4/A B $0.52 $85,540 I/I 164,500 92,488,782 2.1 -
HTWR HeartWare International I... Director   –       •      –    2008-08-20 4 B $0.51 $51,867 I/I 101,700 92,590,482 2.1 -
HTWR HeartWare International I... Director   –       •      –    2008-08-21 4 B $0.52 $95,916 I/I 184,453 92,774,935 2.1 -
HTWR HeartWare International I... Director   –       •      –    2008-08-22 4 B $0.53 $17,834 I/I 33,649 92,808,584 2.1 -
  89  Records found
  1  2   3   4      
  Page 1 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us